Literature DB >> 856013

Plasmid-medicated aminoglycoside phosphotransferase of broad substrate range that phosphorylates amikacin.

P Courvalin, J Davies.   

Abstract

A plasmid-mediated aminoglycoside phosphotransferase that phosphorylates amikacin has been detected in clinical isolates of Staphylococcus aureus. This enzyme does not confer detectable amikacin resistance to the strains.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 856013      PMCID： PMC352039          DOI： 10.1128/AAC.11.4.619

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  Aminoglycoside-modifying enzymes.

Authors:  M J Haas; J E Dowding
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

Review 2.  Mechanisms of antibiotic resistance in bacteria.

Authors:  R Benveniste; J Davies
Journal:  Annu Rev Biochem       Date:  1973       Impact factor: 23.643

3.  Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus.

Authors:  R Novick
Journal:  Virology       Date:  1967-09       Impact factor: 3.616

4.  Enzymes that inactivate antibiotics in transit to their targets.

Authors:  J E Davies; R E Benveniste
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

5.  Evolution of plasmids in vivo in a strain of Staphylococcus aureus.

Authors:  R W Lacey; E Lewis; V T Rosdahl
Journal:  J Med Microbiol       Date:  1974-02       Impact factor: 2.472

6.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

7.  Enzymatic modification of aminoglycoside antibiotics: a new 3-N-acetylating enzyme from a Pseudomonas aeruginosa isolate.

Authors:  S Biddlecome; M Haas; J Davies; G H Miller; D F Rane; P J Daniels
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

8.  New plasmid-mediated nucleotidylation of aminoglycoside antibiotics in Staphlococcus aureus.

Authors:  F Le Goffic; A Martel; M L Capmau; B Baca; P Goebel; H Chardon; C J Soussy; J Duval; D H Bouanchaud
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

9.  Isolation and characterization of a kanamycin resistance plasmid from Staphylococcus aureus.

Authors:  P W Stiffler; H M Sweeney; M Schneider; S Cohen
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191
  9 in total
  32 in total

1.  Effect of aminoglycoside concentration on reaction rates of aminoglycoside-modifying enzymes.

Authors:  G P Bongaerts; J S Vliegenthart
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

Review 2.  The Whys and Wherefores of Antibiotic Resistance.

Authors:  Cameron R Strachan; Julian Davies
Journal:  Cold Spring Harb Perspect Med       Date:  2017-02-01       Impact factor: 6.915

3.  High-level amikacin resistance in Escherichia coli due to phosphorylation and impaired aminoglycoside uptake.

Authors:  M H Perlin; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

4.  Detection of two different kanamycin resistance genes in naturally occurring isolates of Campylobacter jejuni and Campylobacter coli.

Authors:  F C Tenover; P M Elvrum
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

5.  Aminoglycoside phosphotransferase-II-mediated amikacin resistance in Escherichia coli.

Authors:  G P Bongaerts; G M Kaptijn
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

6.  On the significance of enzymes which confer resistance to aminoglycosides.

Authors:  G P Bongaerts
Journal:  Antonie Van Leeuwenhoek       Date:  1981-03       Impact factor: 2.271

7.  Induction of streptomycin uptake in resistant strains of Escherichia coli.

Authors:  J V Höltje
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

8.  Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.

Authors:  C Thornsberry; A L Barry; R N Jones; C N Baker; R E Badal; R R Packer
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

9.  Plasmid-mediated resistance to aminocyclitol antibiotics in group D streptococci.

Authors:  P Courvalin; C Carlier; E Collatz
Journal:  J Bacteriol       Date:  1980-08       Impact factor: 3.490

10.  Plasmid-mediated resistance to lincomycin by inactivation in Staphylococcus haemolyticus.

Authors:  R Leclercq; C Carlier; J Duval; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.